Products
Pruritus in CKD: Working to Provide Quality of Life (Cara Therapeutics and Vifor Co-Supported CE Product Theater)
May 3, 2021 9:00am ‐ May 3, 2021 10:15am
Nephrology nurses care for patients with CKD who complain of severe pruritus that is decreasing their perceived quality of life. This session discusses a nephrology nurse’s role in planning care to improve quality of life for these patients.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
Supported through an educational grant from Cara Therapeutics and Vifor Pharma.
No other commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased ability to plan care for patients with CKD experiencing severe pruritus.
Speaker(s):
- Tracy Anderson-Haag, PharmD, BCPS, BCTXP, Clinical Pharmacy Specialist, Hennepin Healthcare
- Christine M. Chmielewski, MS, CRNP, ANP-BC, CNN-NP, Nephrology Nurse Practitioner, Thomas Jefferson University Hospital
Welcome Remarks /// Breakthrough Innovations: Ways to Increase Kidney Transplantation in 2021
May 3, 2021 10:30am ‐ May 3, 2021 12:00pm
Innovative ways to increase both deceased and living organ donation are being explored. Many programs now transplant kidneys from deceased donors who had hepatitis C. Donors with HIV can now donate kidneys to recipients with HIV (HOPE Act). The Executive Order on Advancing American Kidney Health also has tremendous potential for increasing kidney donation and transplantation. This session reviews ground-breaking paradigms in transplantation.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe innovative methods to increase kidney transplantation.
Speaker(s):
- David Serur, MD, Medical Director of Transplantation, Hackensack Meridian Health
- Matthew Cooper, MD, Director of Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute
- Peter Kennealey, MD, FACS, Associate Professor of Medicine, Surgical Director of Kidney & Pancreas Transplantation, University of Colorado School of Medicine
HIV and Renal Function
May 3, 2021 12:30pm ‐ May 3, 2021 1:30pm
Medications to manage HIV may impact renal function. This session reviews the current state of HIV progression and survivability, first-line drugs used to treat HIV, and the potential impact of these medications on renal function, such as kidney injury and HIV-associated nephropathy (HIVAN).
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to successfully plan care for patients with CKD and HIV based on the knowledge of the relationship between HIV and kidney function.
Speaker(s):
- Casey Martens, MSN, FNP-C, Clinical Training Specialist, Wayne State University
- Tory Ervin, MSN, MPH, AAHIVS, Clinical Training Specialist, MATEC Michigan, Midwest AIDS Education and Training Center
Incremental and Twice-weekly Hemodialysis: A Nephrologist's Overview with Patient Perspective
May 3, 2021 12:30pm ‐ May 3, 2021 1:30pm
Gain insight into another member of the patient care team as a physician shares his perception of his role in patient care and dialysis. This session highlights the patient’s perspective of their disease and how these two views of kidney disease and dialysis are similar and dissimilar.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Kamyar Kalantar-Zadeh, MD, MPH, Phd – Salary from University of California Irvine and Fresenius, DaVita
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe the perspectives of other health care providers about incremental dialysis.
Speaker(s):
- Kamyar Kalantar-Zadeh, MD, MPH, PhD, Professor and Chief of Nephrology, University of California, Irvine
- Nieltje Gedney, BA
Severe Mental Illness and CKD: Is there a Link?
May 3, 2021 3:00pm ‐ May 3, 2021 4:00pm
Nephrology nurses often care for patients with comorbid diseases but may not be as versed in caring for patients with severe mental illness (SMI). This session provides information about symptoms of SMI and research findings on mental health issues and kidney disease. A highlight of this session is the importance of this information to daily practice and how to provide the most effective care to patients with SMI.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe possible links between mental illness and CKD.
Speaker(s):
- Brenda Jahnke, MSN, RN, CNS, House Supervisor, Northern Nevada Medical Center
Blood Pressure Guidelines for Hypertension
May 3, 2021 3:00pm ‐ May 3, 2021 4:00pm
Hyper- and hypotension are a concern for nephrology nurses caring for patients with chronic kidney disease (CKD) receiving dialysis. This session reviews the pathophysiology of hypertension in CKD, compares current hypertension guidelines (KDIGO, ACC/AHA), and addresses the implications of the SPRINT trial on future hypertension guidelines.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to explain the latest guidelines to provide evidence-based care to patients with hypertension.
Speaker(s):
- Wendy St. Peter, FCCP, FASN, FNKF, Professor, University of Minnesota
Abstract Presentations: Clinical or Case Study Focus
May 3, 2021 4:30pm ‐ May 3, 2021 5:30pm
This session includes abstract presentations with a clinical or case study focus.
- Obtaining Hemoglobin S and Hematocrit Levels Post Red Blood Cell Exchange: Target and Actual Result by Kyle Gault, BSN, RN, CNN, CDN, QIA (ASCP)
- The Effect of Educational Intervention (EFEKT) to Improve Blood Pressure Control Among Minority Patients with Chronic Kidney Disease by Anitha Philip, APRN, FNP-C
- Infection Prevention through Collaboration in Hemodialysis Line Care by Nicole Ingram, BSN, RN, CNN
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to interpret studies that address various issues with care of patients with CKD and related conditions.
Speaker(s):
- Kyle Gault, BSN, RN, CNN, CDN, QIA (ASCP), Clinical Nurse, New York Presbyterian Hospital
- Anitha Philip, DNP, RN, FNP-C, Advanced Practice Nurse, Cook County Health
- Nicole Ingram, BSN, RN, CNN, Registered Nurse, Virginia Commonwealth University Health System
Abstract Presentations: Research Focus
May 3, 2021 4:30pm ‐ May 3, 2021 5:30pm
This session includes abstract presentations with a research focus.
- Validity of Self-Report and Objective Fatigue Measures in Hemodialysis by Bincy Joshwa, PhD, MSN, RN
- Kidney Transplant Recipients' Perceptions of Consumer-Based Mobile Health Applications for Self-Health Tracking by Tara O’Brien, PhD, RN, CNE
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe research conducted related to various issues in nephrology care.
Speaker(s):
- Bincy Joshwa, PhD, MSN, RN, Assistant Professor, Wayne State University College of Nursing
- Tara O'Brien, PhD, RN, CNE, Assistant Professor, The Ohio State University College of Nursing
Welcome Remarks /// Back to the Future of Home Dialysis: Lessons from the Past
May 4, 2021 10:30am ‐ May 4, 2021 12:00pm
The Executive Order on Advancing American Kidney Health set a goal of having 80% of individuals with end-stage kidney disease (ESKD) receive home hemodialysis or a pre-emptive transplant. The future of home dialysis will be transformed, but what that future will look like is still to be determined. This session addresses these issues, reflecting on experiences from the 1970s to now and exploring potential future trends.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to recount the history of home dialysis and the current and future implications related to the historical perspectives.
Speaker(s):
- Nupur Gupta, MD, Assistant Professor of Clinical Medicine, Indiana University
The Effect of COVID-19 on Pediatric Nephrology and Transplant
May 4, 2021 12:45pm ‐ May 4, 2021 1:45pm
Learn more about the incidence and presentations of COVID-19 in the pediatric population, as well as changes in pediatric nephrology practice as a result of COVID. The effects of COVID on pediatric transplant protocol is a highlight of this session.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the plan of care for pediatric nephrology and transplant patients with COVID-19 based on current evidence.
Speaker(s):
- Tyson Moore, MSN, APRN, FNP-C, CPN, CNN-NP, Nurse Practitioner, Children's Mercy Hospital